daraprim
Join our newsletter Stay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.

VIDEO: Turing Pharmaceuticals CEO Martin Shkreli: 5,000 Percent Price Boost ‘Not Excessive at All’

Sep 23, 2015
In case you hadn't heard, last month, Turing Pharmaceuticals CEO and former hedge fund manager Martin Shkreli got hold of the rights to parasite-zapping drug Daraprim, and then he had the bright idea to raise the price from $13.50 to $750 per pill. Now he has a big public relations problem and a self-created health care crisis on his hands.